The potential role of glutamate transporters in the pathogenesis of normal tension glaucoma

Journal of Clinical Investigation

Volumn 117, Issue 7, 2007, Pages 1763-1770

  Harada, Takayuki ^a,b,c   Harada, Chikako ^a,b   Nakamura, Kazuaki ^b   Quah, Hun Meng A ^a   Okumura, Akinori ^b   Namekata, Kazuhiko ^b   Saeki, Tadashiro ^d   Aihara, Makoto ^d   Yoshida, Hiroshi ^c   Mitani, Akira ^e   Tanaka, Kohichi ^a,f  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^b TOKYO METROPOLITAN INSTITUTE OF MEDICAL SCIENCE   (Japan)

^c TOKYO METROPOLITAN NEUROLOGICAL HOSPITAL   (Japan)

^d UNIVERSITY OF TOKYO   (Japan)

^e KYOTO UNIVERSITY   (Japan)

^f JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

EXCITATORY AMINO ACID TRANSPORTER 1; GLUTAMATE RECEPTOR ANTAGONIST; GLUTAMATE TRANSPORTER; GLUTATHIONE;

ANIMAL EXPERIMENT; ANIMAL MODEL; AQUEOUS HUMOR FLOW; ARTICLE; BLINDNESS; CONTROLLED STUDY; DISEASE COURSE; EYE BLOOD FLOW; GLAUCOMA; IMMUNOHISTOCHEMISTRY; INTRAOCULAR PRESSURE; MOUSE; NONHUMAN; NORMAL TENSION GLAUCOMA; OPTIC NERVE ATROPHY; OXIDATIVE STRESS; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RETINA GANGLION CELL; RETINA INJURY;

AMINO ACID TRANSPORT SYSTEM X-AG; ANIMALS; DISEASE MODELS, ANIMAL; GENE EXPRESSION REGULATION; GLAUCOMA; GLUTAMIC ACID; INTRAOCULAR PRESSURE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MUTATION; NERVE DEGENERATION; OPTIC NERVE DISEASES; OXIDATIVE STRESS; RETINAL GANGLION CELLS; VISION;

EID: 34447126849     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI30178     Document Type: Article

References (52)

1. Quigley, H.A. 1996. Number of people with glaucoma worldwide. Br. J. Ophthalmol. 80:389-393.
2. Weinreb, R.N., and Khaw, P.T. 2004. Primary openangle glaucoma. Lancet. 363:1711-1720.
3. Klein, B.E., et al. 1992. Prevalence of glaucoma. The Beaver Dam Eye Study. Ophthalmology. 99:1499-1504.
4. Bonomi, L., et al. 1998. Prevalence of glaucoma and intraocular pressure distribution in a defined population. The Egna-Neumarkt Study. Ophthalmology. 105:209-215.
5. Iwase, A., et al. 2004. The prevalence of primary open-angle glaucoma in Japanese: the Tajimi Study. Ophthalmology. 111:1641-1648.
6. Anderson, D.R. 2003. Collaborative normal tension glaucoma study. Curr. Opin. Ophthalmol. 14:86-90.
7. Wiggs, J.L. 2007. Genetic etiologies of glaucoma. Arch. Ophthalmol. 125:30-37.
8. Osborne, N.N., Lascaratos, G., Bron, A.J., Chidlow, G., and Wood, J.P. 2006. A hypothesis to suggest that light is a risk factor in glaucoma and the mitochondrial optic neuropathies. Br. J. Ophthalmol. 90:237-241.
9. Lindsey, J.D., and Weinreb, R.N. 2005. Elevated intraocular pressure and transgenic applications in the mouse. J. Glaucoma. 14:318-320.
10. Danbolt, N.C. 2001. Glutamate uptake. Prog. Neurobiol. 65:1-105.
11. Rauen, T. 2000. Diversity of glutamate transporter expression and function in the mammalian retina. Amino Acids. 19:53-62.
12. Dalton, R. 2001. Private investigations. Nature. 411:129-130.
13. Harada, T., et al. 1998. Functions of the two glutamate transporters GLAST and GLT-1 in the retina. Proc. Natl. Acad. Sci. U. S. A. 95:4663-4666.
14. Watase, K., et al. 1998. Motor discoordination and increased susceptibility to cerebellar injury in GLAST mutant mice. Eur. J. Neurosci. 10:976-988.
15. Peghini, P., Janzen, J., and Stoffel, W. 1997. Glutamate transporter EAAC-1-deficient mice develop dicarboxylic aminoaciduria and behavioral abnormalities but no neurodegeneration. EMBO J. 16:3822-3832.
16. Harada, C., et al. 2006. Role of apoptosis signalregulating kinase 1 in stress-induced neural cell apoptosis in vivo. Am. J. Pathol. 168:261-269.
17. Tanaka, K., et al. 1997. Epilepsy and exacerbation of brain injury in mice lacking the glutamate transporter GLT-1. Science. 276:1699-1702.
18. Aihara, M., Lindsey, J.D., and Weinreb, R.N. 2003. Twenty-four-hour pattern of mouse intraocular pressure. Exp. Eye Res. 77:681-686.
19. Hasegawa, S., Ohshima, A., Hayakawa, Y., Takagi, M., and Abe, H. 2001. Multifocal electroretinograms in patients with branch retinal artery occlusion. Invest. Ophthalmol. Vis. Sci. 42:298-304.
20. Sutter, E.E., and Bearse, M.A., Jr. 1999. The optic nerve head component of the human ERG. Vision Res. 39:419-436.
21. Adachi, K., et al. 1998. Mechanisms of the pathogenesis of glutamate neurotoxicity in retinal ischemia. Graefes Arch. Clin. Exp. Ophthalmol. 236:766-774.
22. Lipton, S.A. 2004. Paradigm shift in NMDA receptor antagonist drug development: molecular mechanism of uncompetitive inhibition by memantine in the treatment of Alzheimer's disease and other neurologic disorders. J. Alzheimers Dis. 6(6 Suppl.):S61-S74.
23. Klein, J.A., et al. 2002. The harlequin mouse mutation downregulates apoptosis-inducing factor. Nature. 419:367-374.
24. Tezel, G. 2006. Oxidative stress in glaucomatous neurodegeneration: mechanisms and consequences. Prog. Retin. Eye Res. 25:490-513.
25. Schulz, J.B., Lindenau, J., Seyfried, J., and Dichgans, J. 2000. Glutathione, oxidative stress and neurodegeneration. Eur. J. Biochem. 267:4904-4911.
26. Huster, D., Reichenbach, A., and Reichelt, W. 2000. The glutathione content of retinal Müller (glial) cells: effect of pathological conditions. Neurochem. Int. 36:461-469.
27. Gherghel, D., Griffiths, H.R., Hilton, E.J., Cunliffe, I.A., and Hosking, S.L. 2005. Systemic reduction in glutathione levels occurs in patients with primary open-angle glaucoma. Invest. Ophthalmol. Vis. Sci. 46:877-883.
28. Sarthy, V.P., et al. 2005. Glutamate transporter in retinal Müller cells from glutamate/aspartate transporter (GLAST) knockout mice. Glia. 49:184-196.
29. Aoyama, K., et al. 2006. Neuronal glutathione deficiency and age-dependent neurodegeneration in the EAAC1 deficient mouse. Nat. Neurosci. 9:119-126.
30. Naskar, R., Vorwerk, C.K., and Dreyer, E.B. 2000. Concurrent downregulation of a glutamate transporter and receptor in glaucoma. Invest. Ophthalmol. Vis. Sci. 41:1940-1944.
31. Zoia, C.P., et al. 2005. Fibroblast glutamate transport in aging and in AD: correlations with disease severity. Neurobiol. Aging. 26:825-832.
32. Tamura, H., et al. 2006. High frequency of open-angle glaucoma in Japanese patients with Alzheimer's disease. J. Neurol. Sci. 246:79-83.
33. Libby, R.T., Gould, D.B., Anderson, M.G., and John, S.W. 2005. Complex genetics of glaucoma susceptibility. Annu. Rev. Genomics Hum. Genet. 6:15-44.
34. Dringen, R., Pfeiffer, B., and Hamprecht, B. 1999. Synthesis of the antioxidant glutathione in neurons: supply by astrocytes of CysGly as precursor for neuronal glutathione. J. Neurosci. 19:562-569.
35. Wu, G., Fang, Y.Z., Yang, S., Lupton, J.R., and Turner, N.D. 2004. Glutathione metabolism and its implications for health. J. Nutr. 134:489-492.
36. Reichelt, W., Stabel-Burow, J., Pannicke, T., Weichert, H., and Heinemann, U. 1997. The glutathione level of retinal Müller glial cells is dependent on the high-affinity sodium-dependent uptake of glutamate. Neuroscience. 77:1213-1224.
37. Riepe, R.E., and Norenburg, M.D. 1977. Müller cell localisation of glutamine synthetase in rat retina. Nature. 268:654-655.
38. Li, Q., and Puro, D.G. 2002. Diabetes-induced dysfunction of the glutamate transporter in retinal Müller cells. Invest. Ophthalmol. Vis. Sci. 43:3109-3116.
39. Ohia, S.E., Opere, C.A., and LeDay, A.M. 2005. Pharmacological consequences of oxidative stress in ocular tissues. Mutation Res. 579:22-36.
40. Lipton, S.A. 2001. Retinal ganglion cells, glaucoma and neuroprotection. Prog. Brain Res. 131:712-718.
41. Yamashita, H., Kawakami, H., Zhang, Y.X., Tanaka, K., and Nakamura, S. 1995. Neuroprotective mechanism of bromocriptine. Lancet. 346:1305.
42. Tanaka, K. 2005. Antibiotics rescue neurons from glutamate attack. Trends Mol. Med. 11:259-262.
43. Harada, T., et al. 2000. Modification of glialneuronal cell interactions prevents photoreceptor apoptosis during light-induced retinal degeneration. Neuron. 26:533-541.
44. Harada, T., et al. 2002. Microglia-Müller glia cell interactions control neurotrophic factor production during light-induced retinal degeneration. J. Neurosci. 22:9228-9236.
45. Ooto, S., et al. 2004. Potential for neural regeneration after neurotoxic injury in the adult mammalian retina. Proc. Natl. Acad. Sci. U. S. A. 101:13654-13659.
46. Harada, T., Harada, C., and Parada, L.F. 2007. Molecular regulation of visual system development: more than meets the eye. Genes Dev. 21:367-378.
47. Bringmann, A., et al. 2006. Müller cells in the healthy and diseased retina. Prog. Retin. Eye Res. 25:397-424.
48. Harada, C., Mitamura, Y., and Harada, T. 2006. The role of cytokines and trophic factors in epiretinal membranes: involvement of signal transduction in glial cells. Prog. Retin. Eye Res. 25:149-164.
49. Rothstein, J.D., et al. 1994. Localization of neuronal and glial glutamate transporters. Neuron. 13:713-725.
50. Fontaine, V., et al. 2002. Neurodegenerative and neuroprotective effects of tumor necrosis factor (TNF) in retinal ischemia: opposite roles of TNF receptor 1 and TNF receptor 2. J. Neurosci. 22:RC216.
51. Aihara, M., Lindsey, J.D., and Weinreb, R.N. 2002. Reduction of intraocular pressure in mouse eyes treated with latanoprost. Invest. Ophthalmol. Vis. Sci. 43:146-150.
52. Mitani, A., and Tanaka, K. 2003. Functional changes of glial glutamate transporter GLT-1 during ischemia: an in vivo study in the hippocampal CA1 of normal mice and of mutant mice lacking GLT-1. J. Neurosci. 23:7176-7182.